Literature DB >> 21807309

Midline congenital malformations of the brain and skull.

Sara Nuñez1, Maria T Mantilla, Sonia Bermúdez.   

Abstract

Considering the complexity of congenital midline abnormalities of the brain, it is mandatory to review and summarize the subject, based on embryologic development, developmental biology, clinical approach, neuroimaging, and molecular genetics. There are still several areas of poor knowledge, confusion, and controversy. Pathogenesis in some cases is not clearly understood, and definitions and limits among different diseases are not apparent. This article reviews several malformations of the skull and brain with the aims of making image interpretation easier, enabling an accurate diagnosis, establishing the prognosis, and aiding in genetic counseling.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21807309     DOI: 10.1016/j.nic.2011.05.001

Source DB:  PubMed          Journal:  Neuroimaging Clin N Am        ISSN: 1052-5149            Impact factor:   2.264


  3 in total

1.  Feasibility and Added Value of Fetal DTI Tractography in the Evaluation of an Isolated Short Corpus Callosum: Preliminary Results.

Authors:  A-E Millischer; D Grevent; P Sonigo; N Bahi-Buisson; I Desguerre; H Mahallati; J-P Bault; T Quibel; S Couderc; M-L Moutard; E Julien; V Dangouloff; B Bessieres; V Malan; T Attie; L-J Salomon; N Boddaert
Journal:  AJNR Am J Neuroradiol       Date:  2021-12-23       Impact factor: 3.825

2.  Ultrasonographic Characteristics of Cortical Sulcus Development in the Human Fetus between 18 and 41 Weeks of Gestation.

Authors:  Xi Chen; Sheng-Li Li; Guo-Yang Luo; Errol R Norwitz; Shu-Yuan Ouyang; Hua-Xuan Wen; Ying Yuan; Xiao-Xian Tian; Jia-Min He
Journal:  Chin Med J (Engl)       Date:  2017-04-20       Impact factor: 2.628

3.  Brain and Optic Chiasm Herniation into Sella after Pituitary Tumor Apoplexy.

Authors:  Maria M Pineyro; Patricia Furtenbach; Ramiro Lima; Saul Wajskopf; Nicolas Sgarbi; Raul Pisabarro
Journal:  Front Endocrinol (Lausanne)       Date:  2017-08-07       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.